DPI Research

The global clinical next generation sequencing (NGS) market size was valued at USD 6.2 billion in 2024 and is projected to surpass around USD 15.2 billion by 2032, registering a CAGR of 13.6% over the forecast period of 2025 to 2032

The global clinical next generation sequencing (NGS) market size was valued at USD 6.2 billion in 2024 and is projected to surpass around USD 15.2 billion by 2032, registering a CAGR of 13.6% over the forecast period of 2025 to 2032

The global clinical next generation sequencing (NGS) market size was valued at USD 6.2 billion in 2024 and is projected to surpass around USD 15.2 billion by 2032, registering a CAGR of 13.6% over the forecast period of 2025 to 2032

The global chimeric antigen receptor (CAR) T-cell therapy market size was valued at USD 4.6 billion in 2024 and is projected to hit around USD 18.1 billion by 2033, growing at a CAGR of 14.6% during the forecast period 2025 to 2033.

DPI Research | The global chimeric antigen receptor (CAR) T-cell therapy market size was valued at USD 4.6 billion in 2024 and is projected to hit around USD 18.1 billion by 2033, growing at a CAGR of 14.6% during the forecast period 2025 to 2033.

Explore the growing trend of halal travel, catering to Muslim travelers around the globe. Discover top halal-friendly destinations in Asia, Europe, and the Middle East that offer halal dining, prayer facilities, and a welcoming atmosphere.

The United States vaccines market size was valued at USD 29.5 billion in 2024 and is projected to hit around USD 60 billion by 2033, growing at a CAGR of 8.2% during the forecast period 2025 to 2033.

The United States insulin pen market size was valued at USD 4.2 billion in 2024 and is projected to hit around USD 8.1 billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025 to 2033.

The U.S. Self-Monitoring Blood Glucose Devices market size was accounted for USD 4,045 million in 2023 and it is expected to reach around USD 7,138 million by 2032 poised to grow at a noteworthy CAGR of 6.5% during the forecast period

Explore the global diabetes insulin delivery pen market, valued at USD 17.7 billion in 2023 and projected to grow to USD 28.7 billion by 2032.